What's Happening?
The U.S. Food and Drug Administration (FDA) has approved bemotrizinol, a sunscreen ingredient widely used in Europe and other countries since 1999. This marks the first approval of a new sunscreen ingredient in the U.S. in over 25 years. Bemotrizinol
offers protection against both UVA and UVB radiation and is minimally absorbed into the skin, making it suitable for use in adults and children from six months of age. The approval aligns with the Trump administration's Make America Healthy Again initiative, which aims to advance innovation in sunscreen products. The ingredient will initially be sold in the U.S. by DSM Nutritional Products under the brand name Parsol Shield, with an 18-month exclusivity period before other manufacturers can incorporate it into their products.
Why It's Important?
The approval of bemotrizinol addresses a significant gap in U.S. sunscreen products, which have been criticized for providing inadequate UVA protection. Current U.S. sunscreens primarily protect against UVB rays, which cause sunburn, but are less effective against UVA rays, which penetrate deeper into the skin and contribute to skin cancer and premature aging. Bemotrizinol's ability to protect against both types of radiation and its photostability make it a valuable addition to the U.S. market. This development is expected to increase competition and consumer confidence in sunscreen products, potentially leading to broader reform in sunscreen regulation and innovation.
What's Next?
Following its launch by DSM Nutritional Products, other manufacturers will be able to use bemotrizinol in their products after the 18-month exclusivity period. Sunscreen manufacturers have welcomed the FDA's decision but urge the agency to continue modernizing its approval processes for sunscreen ingredients. Broader reform proposals, including clearer labeling requirements for active ingredients and SPF levels, remain pending. The approval of bemotrizinol may prompt further regulatory changes and encourage the introduction of more advanced sunscreen formulations in the U.S.
